Preventable Hospital Readmissions
Date: February 16, 2026 Problem: Patients discharged without adequate follow-up cause ~$26B/yr in preventable 30-day readmissions; hospitals face CMS penalties under the Hospital Readmissions Reduction Program (HRRP).
Note: This report draws on published data from CMS, AHRQ, KFF, AHA, peer-reviewed literature, and market research firms (Grand View Research, MarketsandMarkets, Fortune Business Insights) available through early 2025. Where live web retrieval was unavailable, figures reflect the most recent widely-cited data. Sources with URLs are listed in Section 9.
Author: Rigid Body Dynamics
1. PROBLEM MARKET SIZE
Total Cost of Preventable Readmissions in the US
| Metric | Value | Source / Year |
|---|---|---|
| Total cost of all 30-day hospital readmissions (Medicare) | ~$26B per year | CMS / AHRQ, 2023 estimate |
| Estimated share deemed preventable | 50-75% (method-dependent) | Jencks et al. (NEJM); AHRQ |
| Preventable readmission cost (conservative 50%) | ~17B per year | Derived |
| Total cost including all payers (Medicare + Medicaid + commercial) | ~52B per year | Various; AHA estimates |
- The oft-cited "$26 billion" figure originates from Medicare-only data. When Medicaid and commercial payers are included, the aggregate cost is substantially higher.
- CMS estimates that roughly 2 million Medicare beneficiaries are readmitted within 30 days annually, at an average cost of ~15,000 per readmission episode.
CMS HRRP Penalties
| Metric | Value | Source / Year |
|---|---|---|
| Total HRRP penalties (FY 2024) | ~$521 million | CMS Final Rule FY 2024 |
| Total HRRP penalties (FY 2023) | ~$521 million | CMS Final Rule FY 2023 |
| Cumulative penalties since program inception (FY 2013-2024) | ~$6.5 billion | KFF / Advisory Board analysis |
| Maximum penalty per hospital | 3% of base DRG payments | CMS statute |
| Average penalty among penalized hospitals | ~0.64% of base payments (FY 2024) | CMS data |
2. CURRENT SPEND TO MANAGE
Care Management Software Market
| Metric | Value | Source |
|---|---|---|
| Market size (2023) | ~$14.4 billion | Grand View Research |
| Market size (2024, estimated) | ~$16.1 billion | Grand View Research |
| Projected size (2030) | ~36 billion | Grand View Research / MarketsandMarkets |
| CAGR (2024-2030) | 12.1-13.5% | Grand View Research |
Transitional Care / Transition of Care Services Market
| Metric | Value | Source |
|---|---|---|
| Market size (2023) | ~$6.8 billion (US) | MarketsandMarkets |
| Projected size (2030) | ~$14.2 billion | MarketsandMarkets |
| CAGR (2024-2030) | ~11.0% | MarketsandMarkets |
Population Health Management (PHM) Market
| Metric | Value | Source |
|---|---|---|
| Global market size (2023) | ~$31.5 billion | Fortune Business Insights |
| Global market size (2024, estimated) | ~$36.5 billion | Fortune Business Insights |
| Projected size (2030) | ~89 billion | Fortune Business Insights / Grand View Research |
| CAGR (2024-2030) | 14.5-16.2% | Fortune Business Insights |
| US share of global PHM market | ~45-50% | Industry estimates |
Remote Patient Monitoring (RPM) Market (Adjacent)
| Metric | Value | Source |
|---|---|---|
| Market size (2023) | ~$5.9 billion (US) | Grand View Research |
| Projected size (2030) | ~$15.6 billion | Grand View Research |
| CAGR | ~14.9% | Grand View Research |
3. COST OF INACTION
Average Cost of a Single Readmission
| Condition | Avg. Cost per Readmission | Source |
|---|---|---|
| All-cause (Medicare) | 15,200 | AHRQ HCUP, 2023 |
| Heart failure (CHF) | 16,500 | AHRQ |
| COPD | 13,900 | AHRQ |
| Pneumonia | 14,700 | AHRQ |
| Hip/Knee replacement | 16,800 | AHRQ |
| AMI (Acute Myocardial Infarction) | 17,200 | AHRQ |
| CABG (Coronary Artery Bypass Graft) | 21,000 | AHRQ |
CMS Penalty Impact per Hospital
| Metric | Value |
|---|---|
| Maximum HRRP penalty | 3% of total base DRG payments |
| For a mid-size hospital (~$200M Medicare revenue) | Up to $6 million/year |
| For a large academic medical center (~$800M Medicare rev.) | Up to $24 million/year |
| Average penalty among penalized hospitals (FY 2024) | ~350,000 |
| Median penalty (FY 2024) | ~$140,000 |
Percentage of Readmissions Deemed Preventable
- Conservative estimates: 27-30% of all 30-day readmissions are preventable (Auerbach et al., BMJ Quality & Safety, 2016; reaffirmed in 2023 meta-analyses).
- Broader estimates: Up to 75% may be avoidable with optimal discharge planning, medication reconciliation, and follow-up (Jencks et al., NEJM 2009; updated AHRQ analyses).
- CMS working estimate: ~50% of readmissions have a modifiable component.
- Most-cited range in policy discussions: 40-60% preventable.
Impact on Hospital Margins
| Metric | Value | Context |
|---|---|---|
| Average US hospital operating margin (2023) | 2.7% (median) | Kaufman Hall |
| Average US hospital operating margin (2024) | 3.2% (median) | Kaufman Hall |
| HRRP penalty as % of operating margin | Can represent 10-40% of operating profit for penalized hospitals | Derived |
| Readmission cost absorbed by hospital (under bundled/VBC contracts) | 100% of incremental cost | CMS BPCI data |
| Estimated margin erosion from excess readmissions (safety-net hospital) | 1.5-3.0 percentage points | AHA analysis |
Safety-net hospitals and rural hospitals are disproportionately affected. A 2024 AHA analysis showed that hospitals with higher shares of dual-eligible patients face systematically higher HRRP penalties, contributing to a two-tier penalty system that critics call inequitable.
4. VOLUME AND FREQUENCY
Total 30-Day Readmissions
| Metric | Value | Source / Year |
|---|---|---|
| Total Medicare 30-day readmissions per year | ~1.9 - 2.1 million | CMS, 2023-2024 |
| All-payer 30-day readmissions (estimated) | ~3.5 - 3.8 million | AHRQ HCUP extrapolation |
| Overall 30-day readmission rate (Medicare FFS) | ~15.0-15.5% | CMS 2023 data (down from 19.5% in 2010) |
Readmission Rates by Condition (Medicare, 2023-2024)
| Condition | 30-Day Readmission Rate | Trend |
|---|---|---|
| Heart Failure (CHF) | 20.0-21.5% | Declining (was 24.8% in 2010) |
| COPD | 18.5-19.8% | Declining (was 21.1% in 2010) |
| Pneumonia | 15.5-16.8% | Declining (was 18.5% in 2010) |
| AMI | 15.0-16.2% | Declining (was 19.9% in 2010) |
| Hip/Knee Replacement | 4.5-5.2% | Declining (was 5.8% in 2010) |
| CABG | 11.5-12.8% | Declining |
Hospitals Penalized Under HRRP
| Fiscal Year | Hospitals Penalized | % of Eligible Hospitals | Source |
|---|---|---|---|
| FY 2023 | ~2,273 | ~77% | CMS |
| FY 2024 | ~2,180 | ~76% | CMS |
| FY 2025 (projected) | ~2,100-2,200 | ~74-76% | CMS / Advisory Board |
| Total eligible hospitals evaluated | ~2,800-2,900 | -- | CMS |
Key insight: Roughly three-quarters of all evaluated hospitals receive some level of HRRP penalty each year, making this one of the most broadly applied CMS quality penalties.
5. WHY STILL UNSOLVED
Post-Discharge Contact Gaps
- 48-hour follow-up failure: Only 50-55% of discharged patients receive a follow-up call within 48 hours. Evidence shows that structured post-discharge calls within 48-72 hours reduce readmissions by 20-30%.
- 7-day physician follow-up: Only ~40-45% of Medicare patients see their PCP within 7 days of discharge (CMS data, 2023). For CHF patients, this drops to ~38%.
- Medication reconciliation gaps: 50-70% of patients experience at least one medication discrepancy at discharge. Adverse drug events account for ~20% of preventable readmissions.
- Patient comprehension: Studies show 40-80% of medical information provided at discharge is forgotten immediately. Only 12% of adults have proficient health literacy (AHRQ).
Social Determinants of Health (SDOH)
- Food insecurity: Patients with food insecurity have 1.5x higher readmission rates.
- Housing instability: Homeless or housing-insecure patients have 2-3x higher readmission rates.
- Transportation barriers: ~3.6 million Americans miss or delay medical care annually due to transportation issues (AHRQ). This directly affects post-discharge follow-up attendance.
- Social isolation: Patients living alone have 25-30% higher readmission risk, particularly for CHF.
- Dual-eligible patients: Medicare-Medicaid dual-eligible beneficiaries have readmission rates 1.4-1.8x higher than Medicare-only patients.
- Behavioral health comorbidities: Depression increases 30-day readmission risk by 40-50%.
Care Transition Handoff Failures
- Discharge summary delays: Only 12-34% of discharge summaries are available at the time of the first follow-up visit (Kripalani et al., JAMA Internal Medicine).
- PCP notification gaps: ~25% of PCPs report not being notified when their patients are hospitalized.
- Fragmented EHR systems: Despite widespread EHR adoption, interoperability remains poor. Only ~30-40% of hospitals can electronically exchange patient summaries with community providers in real time.
- Handoff protocol non-adherence: Even when structured handoff tools exist (e.g., IDEAL, RED, Project BOOST), adherence rates range from 40-65% due to time pressure and staffing shortages.
Systemic / Structural Barriers
- Nursing shortages: Post-pandemic nursing shortages have reduced discharge planning capacity. The average hospital care manager caseload increased from 15-20 patients to 25-35 patients (2020-2024).
- Fee-for-service incentive misalignment: Under FFS, readmissions generate revenue. Despite HRRP penalties, many hospitals still net positive on readmissions if the penalty is < marginal revenue from the readmit. The transition to value-based care is incomplete (~40% of Medicare payments are VBC as of 2024).
- Short hospital stays / early discharge pressure: Average length of stay has declined from 5.4 days (2010) to 4.6 days (2023), increasing post-discharge vulnerability.
- Limited home health capacity: Home health agencies face their own workforce shortages, leading to delayed or unavailable post-discharge home visits.
6. WILLINGNESS TO PAY SIGNALS
What Hospitals / ACOs / Payers Currently Pay
| Solution Category | Typical Annual Spend per Hospital / Organization | Notes |
|---|---|---|
| Care management / coordination platforms | 1.5M/year | Per hospital; varies by bed count |
| Remote patient monitoring (RPM) programs | 800K/year | Per program; per-patient cost ~175/month |
| Transitional care nurse programs | 600K/year | 2-4 dedicated transitional care nurses |
| Discharge planning software (standalone) | 250K/year | SaaS licensing |
| Population health analytics platforms | 3M/year | Enterprise licenses for large health systems |
| Post-discharge call center services (outsourced) | 400K/year | Per facility |
| SDOH screening and referral platforms | 150K/year | Emerging category (e.g., Unite Us, findhelp) |
| Bundled payment / episode management tools | 1M/year | For BPCI-A participants |
Evidence of Strong Willingness to Pay
-
CMS Bundled Payments (BPCI-A): Over 1,200 hospitals and physician groups participate in BPCI Advanced, taking on financial risk for 90-day episode costs including readmissions. This demonstrates willingness to invest in readmission prevention to retain shared savings.
-
ACO spending on care management: Medicare Shared Savings Program (MSSP) ACOs collectively spent an estimated 3.5 billion on care management infrastructure in 2023-2024.
-
Health system capital allocation: Large health systems (e.g., CommonSpirit, HCA, Ascension) have allocated 200M+ in multi-year investments for population health and care management platforms.
-
Payer investments: United Healthcare, Humana, Aetna, and other major payers have built or acquired care management capabilities costing hundreds of millions annually (e.g., Optum's $13B acquisition of Change Healthcare included care coordination tools; Humana's CenterWell home health investment).
-
ROI evidence driving spend: Multiple studies show 6 return per $1 invested in structured transitional care programs (Naylor et al., Transitional Care Model; Coleman Care Transitions Intervention). This strong ROI evidence supports continued and growing investment.
-
CMS penalty avoidance math: A hospital facing 500K-$2M on readmission reduction programs.
7. MARKET GROWTH RATE
| Market Segment | CAGR (2024-2030) | Source |
|---|---|---|
| Population Health Management | 14.5-16.2% | Fortune Business Insights / Grand View Research |
| Care Management Software | 12.1-13.5% | Grand View Research / MarketsandMarkets |
| Remote Patient Monitoring | 14.9-17.8% | Grand View Research |
| Transitional Care Services | ~11.0% | MarketsandMarkets |
| Clinical Decision Support | ~10.5% | Fortune Business Insights |
| Healthcare AI (broad, relevant subset) | 38-45% | Grand View Research / Precedence Research |
| SDOH Data & Analytics | ~20-25% | Estimated from multiple sources |
Growth Drivers:
- Expansion of CMS value-based care models (ACO REACH, MSSP, BPCI-A)
- HRRP penalty expansion to include additional conditions
- CMS interoperability mandates (TEFCA, information blocking rules)
- AI/ML adoption for predictive readmission risk scoring
- Post-pandemic shift toward hospital-at-home and virtual care
- Medicaid expansion of readmission penalties in multiple states
8. KEY PLAYERS TODAY
Major Care Management / Population Health Platforms
| Company | Est. Revenue (2023-2024) | Focus Area | Notes |
|---|---|---|---|
| Evolent Health (EVH) | ~2.0B (2024 revenue) | Value-based care enablement, specialty care management | Publicly traded; acquired NIA Magellan specialty assets. Strong growth trajectory. |
| Lightbeam Health Solutions | ~50M (estimated) | Population health analytics, care gap closure | Private; serves ~400+ provider organizations. Acquired by Inovalon (2021), which was taken private by Nordic Capital. |
| Medallia | Acquired by Thoma Bravo for $6.4B (2021) | Patient experience, not core care management | Primarily CX platform; healthcare vertical is a subset. Less directly relevant to readmission prevention. |
| Caradigm (now part of GE HealthCare / legacy) | Largely sunset | Was a Microsoft-GE joint venture for PHM | Dissolved/absorbed; no longer a standalone player. |
Other Significant Players in This Space
| Company | Est. Revenue (2023-2024) | Focus Area |
|---|---|---|
| Optum / UnitedHealth Group | >$20B (Optum Health segment) | End-to-end care management, analytics, population health |
| Epic Systems (Healthy Planet module) | ~$4.6B total (2023) | Embedded PHM within EHR; dominant in large health systems |
| Cerner / Oracle Health | ~$6B+ (Oracle Health Cloud) | EHR + population health; Oracle investment in AI |
| Health Catalyst (HCAT) | ~320M (2024) | Data analytics, outcomes improvement, care management |
| Innovaccer | ~200M (estimated) | Health data platform, care management, PHM |
| CarePort Health (WellSky) | Part of WellSky (~$600M total) | Post-acute care coordination, discharge planning |
| Bamboo Health | ~150M (estimated) | Care coordination, real-time patient alerts, PDMP |
| PointClickCare | ~700M (estimated) | Post-acute / long-term care EHR and care coordination |
| Enhabit Home Health & Hospice | ~$1.1B (2023) | Home health services for post-discharge care |
| Amedisys (merging with UHS/Optum) | ~$1.9B (2023) | Home health; acquired by UnitedHealth/Optum |
| Unite Us | ~100M (estimated) | SDOH referral network |
| Current Health (Best Buy Health) | Part of Best Buy Health | Hospital-at-home, RPM for transitional care |
| Biofourmis | ~80M (estimated) | AI-driven RPM, hospital-at-home |
Competitive Landscape Summary
The market is fragmented. No single vendor provides a complete readmission-prevention solution spanning predictive analytics + care coordination + post-discharge engagement + SDOH integration + RPM. This creates opportunity for:
- Integrated platforms that unify these capabilities
- AI-first solutions that can predict and intervene more effectively than rule-based systems
- Solutions targeting the specific gap between hospital discharge and primary care re-engagement (the "danger zone" of 3-14 days post-discharge)
9. KEY SOURCES
Government and Regulatory Sources
- CMS Hospital Readmissions Reduction Program (HRRP) -- https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/hospital-readmissions-reduction-program-hrrp
- CMS FY 2024 IPPS Final Rule (readmission penalty data) -- https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps
- AHRQ Healthcare Cost and Utilization Project (HCUP) -- Readmission statistics and costs -- https://hcup-us.ahrq.gov/reports/statbriefs/sb248-Hospital-Readmissions-2010-2016.jsp
- AHRQ Health Literacy data -- https://www.ahrq.gov/health-literacy/index.html
- CMS BPCI Advanced Model -- https://innovation.cms.gov/innovation-models/bpci-advanced
Research and Policy Organizations
- Kaiser Family Foundation (KFF) -- HRRP Analysis -- https://www.kff.org/medicare/issue-brief/aiming-for-fewer-hospital-u-turns-the-medicare-hospital-readmission-reduction-program/
- Jencks SF, Williams MV, Coleman EA. "Rehospitalizations among Patients in the Medicare Fee-for-Service Program." NEJM 2009;360:1418-28 -- https://www.nejm.org/doi/full/10.1056/NEJMsa0803563
- Kripalani S et al. "Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians." JAMA Internal Medicine -- https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/410956
- Naylor MD et al. Transitional Care Model -- https://www.nursing.upenn.edu/ncth/transitional-care-model/
- Coleman EA. Care Transitions Intervention -- https://caretransitions.org/
Industry Analysis and Market Research
- Advisory Board / Optum Advisory -- Hospital Penalty Analysis FY 2024 -- https://www.advisory.com/daily-briefing/2023/10/04/hospital-readmission-penalties
- Kaufman Hall -- National Hospital Flash Report (operating margins) -- https://www.kaufmanhall.com/insights/research-report/national-hospital-flash-report
- American Hospital Association (AHA) -- Hospital statistics and HRRP equity concerns -- https://www.aha.org/
- Grand View Research -- Care Management Solutions Market -- https://www.grandviewresearch.com/industry-analysis/care-management-solutions-market
- Grand View Research -- Population Health Management Market -- https://www.grandviewresearch.com/industry-analysis/population-health-management-market
- MarketsandMarkets -- Transitional Care Management Market -- https://www.marketsandmarkets.com/
- Fortune Business Insights -- Population Health Management Market -- https://www.fortunebusinessinsights.com/population-health-management-market-103037
Company / Financial Sources
- Evolent Health -- SEC filings, investor presentations -- https://ir.evolenthealth.com/
- Health Catalyst -- SEC filings -- https://ir.healthcatalyst.com/
- Innovaccer -- Company information -- https://innovaccer.com/
- WellSky / CarePort -- https://wellsky.com/
- PointClickCare -- https://pointclickcare.com/
Additional Research
- Auerbach AD et al. "Preventability and Causes of Readmissions in a National Cohort of General Medicine Patients." JAMA Internal Medicine 2016 -- https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2498846
- Figueroa JF et al. "Characteristics and Outcomes of US Hospitals Penalized Under the HRRP." BMJ 2023 -- https://www.bmj.com/
- CMS Medicare Shared Savings Program -- ACO data -- https://www.cms.gov/medicare/payment/fee-for-service-providers/shared-savings-program
EXECUTIVE SUMMARY
Preventable hospital readmissions represent a **41-52B. The CMS HRRP program penalizes ~76% of evaluated hospitals, extracting ~6.5B since inception. Despite these financial pressures and a decade of focused attention, 30-day readmission rates remain stubbornly high at ~15% overall and >20% for heart failure.
The root causes are multi-factorial: post-discharge follow-up gaps (only ~50% of patients get a 48-hour call), medication reconciliation failures (50-70% have discrepancies), SDOH barriers (transportation, food, housing), fragmented health IT interoperability, and workforce shortages in care management. The transition from fee-for-service to value-based care remains incomplete (~40% of Medicare payments).
The addressable software/services market is large and fast-growing: care management software (36B, 15-16% CAGR), and remote patient monitoring (1-5M/year per hospital), VBC shared savings, and demonstrated 2-6x ROI on transitional care investments.
The market remains fragmented with no dominant integrated solution. The highest-value opportunity lies in AI-driven platforms that unify predictive risk scoring, automated post-discharge engagement, SDOH screening/referral, and real-time care coordination across the hospital-to-home transition gap.
Report compiled February 16, 2026. Data primarily from 2023-2025 sources. Revenue estimates for private companies are approximations based on available industry reporting and should be validated with primary research.